Robert Liang is an experienced AI data scientist with a background in biochemistry and IT. They served as a Senior Scientific Researcher at GSK from 2005 to 2017, where they contributed to oncology and immunology research. Currently, Robert is a Co-Founder at Shanghai Micro-Science Biotechnology and a Director of Translational Bioanalytics & AI Strategy at Johnson & Johnson, where they lead cross-functional teams to enhance drug development through AI integration. They are also pursuing an M.S. in Biomathematics, Bioinformatics, and Computational Biology at Fudan University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices